Current regulations require that departments of pathology have a structured and active program of quality assurance (QA) and quality improvement (QI), with the goals of enhancing patient safety, minimizing error, ensuring timely delivery of reports, and monitoring physician competence. Types of potential error may evolve over time and, as regulations become progressively more stringent, QA/QI programs need to be constantly updated. The Association of Directors of Anatomic and Surgical Pathology (ADASP) herein provides guidelines for QA and QI in surgical and autopsy pathology.
T he Association of Directors of Anatomic and Surgical Pathology (ADASP, www.adasp.org), which was founded in 1989, first published recommendations for anatomic pathology quality control and quality assurance in 1991. 2 This paper emphasized surgical pathology and autopsy pathology quality issues and did not address cytopathology or specialized anatomic pathology laboratories such as immunohistochemistry or electron microscopy.
In the decade and a half since the original ADASP recommendations, the emphasis on quality improvement has grown tremendously, and a variety of contributions to this area of anatomic pathology have been made by ADASP, The College of American Pathologists, and single institutional studies. [1] [2] [3] [5] [6] [7] [8] [9] [10] [11] [12] [13] [15] [16] [17] [18] The 1999 Institute of Medicine Report, To Err is Human: Building a Safer Health System, further focused attention on medical errors and patient safety and also offered specific recommendations for improvement. 4 The current publication updates and refines the 1991 ADASP recommendations for quality assurance and improvement in surgical and autopsy pathology. As in the original paper, these recommendations take into consideration the structure, responsibilities, and needs of academic anatomic pathology laboratories that have active residency or fellowship programs. These recommendations can be modified according to specific institutional circumstances and needs. : It is recommended that incidents in which there is significant patient harm or there is significant breach of known policies and procedures be fully investigated, reviewed and possible changes in policy or procedure be made to address the problem.
A formal root cause analysis may often be helpful. These should also be referred to the institutional QI committee and risk management. 12. Pathologist competence 14 : JCAHO standards state that ''at the time of renewal of privileges, the organized medical staff evaluates individuals for their continued ability to provide quality care, treatment, and services for the privileges requested as defined in the medical staff bylaws.'' Therefore, pathologists may be required to document evidence of acceptable performance. This may be carried out by collecting individual performance data on multiple parameters and always submitting these data in the context of peer group comparison. These data may include but are not limited to TAT, frozen section/permanent section concordance rates, diagnostic error rates, clinician complaints, or clinician satisfaction.
